[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Pages 5116-5117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01818]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee.

    Times and Dates:
    8:00 a.m.-5:45 p.m., February 25, 2015.
    8:00 a.m.-1:00 p.m., February 26, 2015.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate use of immunizing agents. In addition, under 
42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines. Further, under provisions of the Affordable Care Act, 
at section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been adopted by the Director 
of the Centers for Disease Control and Prevention must be covered by 
applicable health plans.
    Matters for discussion: The agenda will include discussions on: 
General recommendations; meningococcal vaccines; human 
papillomavirus vaccines; influenza;

[[Page 5117]]

novel influenza (H5N1) vaccines, tetanus, diphtheria, and acellular 
pertussis (Tdap) vaccine; hepatitis vaccines; new hexavalent vaccine 
work group; yellow fever vaccine; smallpox vaccine in laboratory 
personnel; and vaccine supply. Recommendation votes are scheduled 
for general recommendations, meningococcal vaccines, influenza, 
novel influenza H5N1 vaccine, yellow fever vaccine, smallpox 
vaccine, and human papillomavirus vaccines. Time will be available 
for public comment.
    Agenda items are subject to change as priorities dictate.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, National Center 
for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road 
NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836; Email 
<a href="/cdn-cgi/l/email-protection#4405070d14040700076a030b12"><span class="__cf_email__" data-cfemail="0445474d54444740472a434b52">[email protected]</span></a>.
    Meeting is webcast live via the World Wide Web; for instructions 
and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/acip/index.html.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-01818 Filed 1-29-15; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>